Site Members can sign up for company wide alerts
Investigation Overview
October 7, 2016 (Shareholders Foundation) - An investigation on behalf of investors of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) shares over potential securities laws violations by Alnylam Pharmaceuticals and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchase...
You must register (for free) or login to view the entire investigation.